ONCTERNAL THERAPEUTICS INC ONCT 深 滬
已收盤 09-20 16:00:00 美东时间
1.53
-0.170
-10.00%
華盛通- 最 高1.70
- 今 開1.70
- 成交量 2.81万股
- 最 低 1.52
- 昨 收 1.70
- 總市值 452.83万
- 52周最高 13.14
- 市盈率 靜 --
- 換手率 0.95%
- 52周最低 1.32
- 委 比 99.68%
- 總股本 295.96万
- 歷史最高 211.20
- 量 比 0.17
- 振 幅 10.59%
- 歷史最低 1.52
- 每 手 1
- 風險率 1.89%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oncternal Therapeutics Restructures Amid Clinical Setbacks
Oncternal Therapeutics ( ($ONCT) ) has shared an announcement. Oncternal Therap...
09-13 05:18
快讯 | Oncternal Therapeutics：员工减少约10人
Oncternal Therapeutics : Workforce Reduction of About 10 Employees
09-13 05:04
Brookline Capital Downgrades Oncternal Therapeutics to Hold
Brookline Capital analyst Kemp Dolliver downgrades Oncternal Therapeutics (NASDAQ:ONCT) from Buy to Hold.
09-12 23:16
Oncternal plunges on portfolio shakeup
Shares of nanocap biotech Oncternal Therapeutics (NASDAQ:ONCT) fell sharply in the morning hours on Thursday after the cancer drug developer announced plans to halt its product development activities ...
09-12 22:09
HC Wainwright & Co. Maintains Buy on Oncternal Therapeutics, Lowers Price Target to $18
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Oncternal Therapeutics (NASDAQ:ONCT) with a Buy and lowers the price target from $19 to $18.
08-12 17:52
快讯 | Oncternal Therapeutics，Inc.：H.C. Wainwright将目标价从$19下调至$18
Oncternal Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $18 From $19
08-09 20:28
Oncternal Therapeutics Q2 2024 GAAP EPS $(2.89) Beats $(3.10) Estimate, Sales $801.000K Beat $237.500K Estimate
Oncternal Therapeutics (NASDAQ:ONCT) reported quarterly losses of $(2.89) per share which beat the analyst consensus estimate of $(3.10) by 6.77 percent. The company reported quarterly sales of $801.000 thousand which
08-09 04:24
快讯 | oncternal therapeutics: 截至2024年6月30日，现金、现金等价物和开空投资总额达2140万美元；现金储备量预计可支持运营至2025年第一季度。
Oncternal Therapeutics : Cash, Cash Equivalents and Short-Term Investments Tota...
08-09 04:05
快讯 | oncternal therapeutics第二季度基本每股收益-2.89美元
Oncternal Therapeutics Q2 Basic EPS USD -2.89
08-09 04:01
快讯 | oncternal therapeutics第二季度营业费用为966.4万美元
Oncternal Therapeutics Q2 Operating Expenses USD 9.664 Million
08-09 04:01
